product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
HMGN2 (D9B9) XP® Rabbit mAb
catalog :
9437
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D9B9
reactivity :
human, mouse, rat, dog
application :
western blot, immunocytochemistry, immunoprecipitation, chromatin immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • chromatin immunoprecipitation; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 5c
Schauwecker S, Kim J, Licht J, Clevenger C. Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells. J Biol Chem. 2017;292:2237-2254 pubmed publisher
  • immunoprecipitation; human; 1:2000; loading ...; fig 2b
  • western blot; human; 1:2000; loading ...; fig 2b
Medler T, Craig J, Fiorillo A, Feeney Y, Harrell J, Clevenger C. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth. Mol Cancer Res. 2016;14:994-1008 pubmed
product information
SKU :
9437P
Product-Name :
HMGN2 (D9B9) XP® Rabbit mAb
Size :
40 ul
Price-(USD) :
135 USD
Species-x-Reactivity :
H, M, R, Mk, (B, Dg, Pg, GP, Hr)
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
17
Host :
Rabbit
Target :
HMGN2
Primary-Protein :
HMGN2
Alt-Names :
HMG17,HMGN2,High mobility group nucleosome-binding domain-containing protein 2,MGC5629,MGC88718,Non-histone chromosomal protein HMG-17,high mobility group protein N2,high-mobility group (nonhistone chromosomal) protein 17,high-mobility group nucleosomal binding domain 2,nonhistone chromosomal protein HMG-17
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.